Christopher E. Brightling

Jack C. Bridge¹, 

Jonathan W. Aylott², 

Christopher E. Brightling⁵, 

Amir M. Ghaemmaghami³, 

Alan J. Knox⁴, 

Mark P. Lewis⁶, 

Felicity R.A.J. Rose¹, 

Gavin E. Morris¹ 

¹Division of Drug Delivery and Tissue Engineering, University of Nottingham, 

²Laboratory of Biophysics and Surface Analysis, School of Pharmacy, University of Nottingham, 

³Division of Immunology and Allergy, School of Molecular Medical Sciences, University of Nottingham, 

⁴Division of Respiratory Medicine, School of Clinical Sciences, University of Nottingham, 

⁵NIHR Respiratory Biomedical Research Unit, University of Leicester, 

⁶School of Sport, Exercise, and Health Sciences, Loughborough University